Barclays Maintains Equal-Weight on SoFi Technologies, Raises Price Target to $12

-6.77% Pre

SoFi

SOFI

0.00

Barclays analyst Terry Ma maintains SoFi Technologies (NASDAQ: SOFI) with a Equal-Weight and raises the price target from $11 to $12.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Pre-Bell Movers | KZIA Adds Vastly 70.1%; Here Are 20 Stocks Moving Premarket

Options Corner: Profiting From The 'Hidden Geometry' Of SoFi Technologies

SoFi (SOFI): Examining Valuation After Three-Year Total Shareholder Return Surges 473%

Jiayin Group Inc. (NASDAQ:JFIN) CEO Dinggui Yan's holdings dropped 12% in value as a result of the recent pullback

MARS Energy Group Acquires Nelnet Renewable Energy, Expanding National Commercial Solar Capabilities

8 Financials Stocks Whale Activity In Today's Session

How Investors Are Reacting To Credit Acceptance (CACC) Securing $500 Million in Lower-Cost Financing

Stock Ratings | HC Wainwright & Co. maintained its "buy" rating on Cullinan Therapeutics (CGEM) and raised its price target from $24 to $26, representing a potential upside of 198.17%.